Hanmi Pharm. Statistics

Total Valuation

Hanmi Pharm. has a market cap or net worth of KRW 3.04 trillion. The enterprise value is 3.50 trillion.

Market Cap	3.04T
Enterprise Value	3.50T

Important Dates

The next estimated earnings date is Wednesday, April 30, 2025.

Earnings Date	Apr 30, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Hanmi Pharm. has 12.68 million shares outstanding. The number of shares has decreased by -0.08% in one year.

Current Share Class	n/a
Shares Outstanding	12.68M
Shares Change (YoY)	-0.08%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	7.81%
Owned by Institutions (%)	20.50%
Float	6.20M

Valuation Ratios

The trailing PE ratio is 25.03 and the forward PE ratio is 20.89. Hanmi Pharm.'s PEG ratio is 6.33.

PE Ratio	25.03
Forward PE	20.89
PS Ratio	2.03
PB Ratio	2.45
P/TBV Ratio	2.92
P/FCF Ratio	19.69
P/OCF Ratio	15.70
PEG Ratio	6.33

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.28, with an EV/FCF ratio of 22.67.

EV / Earnings	28.82
EV / Sales	2.34
EV / EBITDA	11.28
EV / EBIT	16.45
EV / FCF	22.67

Financial Position

The company has a current ratio of 1.09, with a Debt / Equity ratio of 0.40.

Current Ratio	1.09
Quick Ratio	0.63
Debt / Equity	0.40
Debt / EBITDA	1.60
Debt / FCF	3.22
Interest Coverage	8.72

Financial Efficiency

Return on equity (ROE) is 12.00% and return on invested capital (ROIC) is 7.79%.

Return on Equity (ROE)	12.00%
Return on Assets (ROA)	6.78%
Return on Invested Capital (ROIC)	7.79%
Return on Capital Employed (ROCE)	15.88%
Revenue Per Employee	641.85M
Profits Per Employee	52.07M
Employee Count	2,330
Asset Turnover	0.76
Inventory Turnover	2.30

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.84% in the last 52 weeks. The beta is 0.59, so Hanmi Pharm.'s price volatility has been lower than the market average.

Beta (5Y)	0.59
52-Week Price Change	-20.84%
50-Day Moving Average	246,470.00
200-Day Moving Average	281,780.00
Relative Strength Index (RSI)	51.03
Average Volume (20 Days)	40,060

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Hanmi Pharm. had revenue of KRW 1.50 trillion and earned 121.32 billion in profits. Earnings per share was 9,566.83.

Revenue	1.50T
Gross Profit	817.04B
Operating Income	212.51B
Pretax Income	171.25B
Net Income	121.32B
EBITDA	309.84B
EBIT	212.51B
Earnings Per Share (EPS)	9,566.83

Full Income Statement

Balance Sheet

The company has 193.20 billion in cash and 496.69 billion in debt, giving a net cash position of -303.49 billion or -23,934.30 per share.

Cash & Cash Equivalents	193.20B
Total Debt	496.69B
Net Cash	-303.49B
Net Cash Per Share	-23,934.30
Equity (Book Value)	1.24T
Book Value Per Share	85,557.97
Working Capital	63.55B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 193.49 billion and capital expenditures -39.26 billion, giving a free cash flow of 154.23 billion.

Operating Cash Flow	193.49B
Capital Expenditures	-39.26B
Free Cash Flow	154.23B
FCF Per Share	12,162.70

Full Cash Flow Statement

Margins

Gross margin is 54.63%, with operating and profit margins of 14.21% and 8.11%.

Gross Margin	54.63%
Operating Margin	14.21%
Pretax Margin	11.45%
Profit Margin	8.11%
EBITDA Margin	20.72%
EBIT Margin	14.21%
FCF Margin	10.31%

Dividends & Yields

This stock pays an annual dividend of 500.00, which amounts to a dividend yield of 0.21%.

Dividend Per Share	500.00
Dividend Yield	0.21%
Dividend Growth (YoY)	150.00%
Years of Dividend Growth	7
Payout Ratio	10.35%
Buyback Yield	0.08%
Shareholder Yield	0.30%
Earnings Yield	3.99%
FCF Yield	5.08%

Dividend Details

Stock Splits

The last stock split was on December 27, 2023. It was a forward split with a ratio of 1.02.

Last Split Date	Dec 27, 2023
Split Type	Forward
Split Ratio	1.02

Scores

Hanmi Pharm. has an Altman Z-Score of 4.61.

Altman Z-Score	4.61
Piotroski F-Score	n/a